Clinical outcomes associated with referral-based continuous glucose monitoring using a central standardized interpretation strategy

Diabetes Technology and Therapeutics

Volumn 14, Issue 9, 2012, Pages 765-771

  Miele, Anthony ^a   Weiland, Karen ^b   Dungan, Kathleen M ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; INTERHOSPITAL COOPERATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STANDARDIZATION;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MONITORING, AMBULATORY; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84865766076     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0081     Document Type: Article

References (9)

1. Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, Coyle C, Goalen M, Murad MS, Erwin PJ, Corpus J, Montori VM, Murad MH: Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol 2011;5:952-965.
2. Pickup JC, Freeman SC, Sutton AJ: Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self-monitoring of blood glucose: metaanalysis of randomized controlled trials using individual patient data. BMJ 2011;343:d3805.
3. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50.
4. Klonoff DC: Continuous glucose monitoring: roadmap for 21st Century diabetes therapy. Diabetes Care 2005;28:1231-1239.
5. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo-and hyperglycemia: the Guardian continuous monitoring system. Diabetes Technol Ther 2004;6:105-113.
6. Blevins TC: Professional continuous glucose monitoring in clinical practice 2010. J Diabetes Sci Technol 2010;4:440-456.
7. Nardacci EA, Bode BW, Hirsch IB: Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice. Diabetes Educ 2010;36(Suppl 1):4S-19S.
8. Medtronic. www.medtronic.com (accessed December 20, 2011).
9. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.